Testing is one piece of reopening, but experts are still relying on the help of a vaccine to keep the public safe. Researchers are increasingly optimistic that scientists are getting closer to development even though we’re barely months into identifying and learning about the novel strain of SARS. Human and clinical trials are well underway, but just when they’ll be ready for manufacturing and distribution is another story. What is a realistic timeline and does one exist? We asked Dr. Vincent Silenzio an expert in urban and global public health at Rutgers University. To read the full story.
Recent Posts
- New COVID-19 Drug Shows Greater Promise Against Resistant Viral Strains.
- How a new library is set to transform this underserved N.J. community
- Poll Finds Majority of New Jerseyans Give Negative Ratings to State and National Economy.
- New NJACTS Publication
- One Rule Change Would Help Tens of Thousands of New Jersey Families Pay for Childcare
Categories
- Community (2,243)
- Covid (985)
- CTO Events (6)
- News (2,858)
- Pilots (21)